Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia

Fasting hypoglycemia is a known complication of mercaptopurine (6MP) maintenance therapy for acute lymphoblastic leukemia (ALL). It is associated with high levels of the methylated metabolite 6-methyl-mercaptopurine (6MMP). Symptoms of hypoglycemia include morning tremulousness, nausea and vomiting....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Melissa, Bostrom, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Clinical Practice Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392151/
https://www.ncbi.nlm.nih.gov/pubmed/30828444
http://dx.doi.org/10.12688/f1000research.17760.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392151/
https://www.ncbi.nlm.nih.gov/pubmed/30828444
http://dx.doi.org/10.12688/f1000research.17760.2

Ejemplares similares